Hirsutism in adolescent girls

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 4, 2007, Pages 473-474

  Büyükgebiz, Atilla ^a  

^a ACIBADEM HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CORTICOTROPIN; CYTOCHROME P450 17; GONADOTROPIN; HYDROXYPROGESTERONE; INSULIN; PRASTERONE SULFATE; STEROID; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE;

ADOLESCENT; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN TEST; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GONADOTROPIN RELEASE; HAIR FOLLICLE; HAIR GROWTH; HIRSUTISM; HUMAN; HYDROXYLATION; HYPERINSULINEMIA; INSULIN RESISTANCE; NOTE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; STEROIDOGENESIS;

EID: 34249883560     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.4.473     Document Type: Note

References (14)

1. Siklar Z, Öçal G, Adiyaman P, Ergur A, Berberoǧlu M. Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche. J Pediatr Endocrinol Metab 2007; 20: 475-481.
2. Bayram F, Unluhizarci K, Kelestimur F. Potential utility of insulin sensitizers in the treatment of patients with polycystic ovary syndrome. Treat Endocrinol 2002; 1; 45-53.
3. Unluhizarci K, Gokce C, Atmaca H, Bayram F, Kelestimur F. A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue. Exp Clin Endocrinol Diabetes 2004; 112: 504-509.
4. Moran C, Aziz R, Weintrob S, Witcel SF, Rohmer V, Dewailly JA, Marcondes JAM, Pugeat M, Speiser PW, Pignatelli D, Mendonca BB, Bachega TAS, Escobar Morreale HF, Carmina E, Fruzzetti F, Kelestimur F. Reproductive outcome of women with 21 hydroxylase deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91: 3451-3456.
5. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003; 349: 766-788.
6. Ibanez L, Vals C, Potau N, Marcos MV, de Zegher F. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low birth weight effect. Clin Endocrinol (Oxf) 2001; 55: 667-672.
7. Franks S, Gharani M, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update 2001; 7: 405-410.
8. Franks S. The 17 α-hydroxylase/17,20 lyase gene (CYP 17) and polycystic ovary syndrome. Clin Endocrinol (Oxf) 1997; 46: 135-136.
9. Rosenfield RL, Barnes RB, Cara JF. Dysregulation of cytochrome P459c17α as a cause of polycystic ovary syndrome. Fertil Steril 1990; 53: 785-791.
10. Barnes RB, Rosenfield RL, Burnstein S. Pituitary ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 1989; 320: 559-565.
11. Sahin S, Kelestimur F. 17 Hydroxyprogesterone responses to gonadotrophin releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P45017α dysregulation. Hum Reprod 1997; 12: 910-913.
12. Atmaca H, Tanriverdi F, Unluhizarci K, Bayram F, Kelestimur F. Investigation of adrenal functions in patients with idiopathic hyperandrogenemia. Eur J Endocrinol 2006; 155: 307-311.
13. Patel L, Clayton PE. Clinical usefulness of the low dose ACTH test. J Endocrinol Invest 1999; 22: 401-404.
14. Colak R, Kelestimur F, Unluhizarci K, Bayram F, Sahin Y, Tutus A. A comparison between the effects of low dose and standard dose ACTH stimulation tests on adrenal P450c17α enzyme activity in women with polycystic ovary syndrome. Eur J Endocrinol 2002; 147: 473-477.